Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.
Sign up for the BIO.News Newsletter >
June 16-19, 2025 | Boston, MA
April 7-9, 2025Basel, Switzerland
San Francisco, CA
Miami, FL | 2026
Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.
Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.
BIO and PhRMA submitted joint comments on the U.S. Food and Drug Administration’s Information Technology Strategy (Docket No. FDA-2023-N-3636)
BIO and PhRMA submitted joint comments on the U.S. Food and Drug Administration’s Information Technology Strategy (Docket No. FDA-2023-N-3636)